Abivax Re-Engages Centerview as It Eyes Major Pharma Partnerships After $874M Raise
Abivax has resumed partnership talks with major pharma companies via Centerview Partners while preparing a potential independent U.S. launch of obefazimod.
NOTRELOAD AI
Mizuho Analyst Calls Cadence and Synopsys Dip a Buying Opportunity After Kimi K3 AI Chip Shock
Mizuho sees agentic AI tripling the EDA market and maintains Outperform ratings.
Meta in Early Talks to Lease $10 Billion AI Compute Capacity to Anthropic
The move could create a new revenue stream for Meta while helping Anthropic reduce reliance on its existing SpaceX contract.
Seaport Downgrades Sonic Automotive to Neutral on Valuation Concerns
The firm remains constructive on the auto retail sector.
Zentalis Pharmaceuticals Gets Outperform Rating from Mizuho on Azenosertib Potential
Analyst highlights 75% upside potential ahead of key Phase 2 DENALI data readout for lead drug azenosertib.
Travelers Delivers Standout Q2 Results as Core Income Nearly Doubles Estimates
Lower catastrophe losses and strong investment income drove the results.